Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 13.03% |
| 2 | Healthcare | 11.97% |
| 3 | Financials | 8.32% |
| 4 | Utilities | 7.31% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Regency Centers
REG
$14.7B
| $3.47M | 0.01% |
+64,479
| New | +$3.6M |
|
|
GNMK
1502
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.47M | 0.01% |
386,891
+313,339
| +426% | +$3.37M |
|
|
CBM
1503
DELISTED
Cambrex Corporation
CBM
| $3.46M | 0.01% |
185,503
+127,731
| +221% | +$2.74M |
|
1504
CSX Corp
CSX
$93.4B
| $3.46M | 0.01% |
+323,679
| New | +$3.34M |
|
1505
GameStop
GME
$9.75B
| $3.46M | 0.01% |
335,592
-287,792
| -46% | -$3.06M |
|
|
1506
Mastercard
MA
$502B
| $3.46M | 0.01% |
46,738
-1,369,023
| -97% | -$104M |
|
1507
Trex
TREX
$4.51B
| $3.45M | 0.01% |
399,312
-14,120
| -3% | -$118K |
|
|
LORL
1508
DELISTED
Loral Space and Communications, Inc.
LORL
| $3.45M | 0.01% |
47,993
-69,651
| -59% | -$5.13M |
|
1509
LeMaitre Vascular
LMAT
$2.32B
| $3.44M | 0.01% |
500,000
| – | – |
|
1510
FS KKR Capital
FSK
$2.96B
| $3.42M | 0.01% |
79,360
-36,785
| -32% | -$1.54M |
|
|
SRCI
1511
DELISTED
SRC Energy Inc
SRCI
| $3.41M | 0.01% |
279,865
+241,851
| +636% | +$3.02M |
|
1512
Booz Allen Hamilton
BAH
$8.39B
| $3.41M | 0.01% |
145,658
+93,672
| +180% | +$2.06M |
|
1513
CALL
D.R. Horton
DHI
$40B
| $3.41M | 0.01% |
166,100
| – | – |
|
1514
Pediatrix Medical
MD
$2.18B
| $3.4M | 0.01% |
62,056
+44,718
| +258% | +$2.54M |
|
|
CLVS
1515
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.4M | 0.01% |
+75,000
| New | +$3.13M |
|
|
MNTA
1516
PUT
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.4M | 0.01% |
300,000
+109,900
| +58% | +$1.25M |
|
1517
Nektar Therapeutics
NKTR
$2.39B
| $3.4M | 0.01% |
18,767
-8,579
| -31% | -$1.64M |
|
|
SQBK
1518
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $3.39M | 0.01% |
176,367
+146,944
| +499% | +$2.79M |
|
1519
Stagwell
STGW
$2.07B
| $3.39M | 0.01% |
176,662
+134,984
| +324% | +$2.84M |
|
1520
Revvity
RVTY
$12.6B
| $3.38M | 0.01% |
77,591
-210,461
| -73% | -$9.58M |
|
1521
PUT
RH
RH
$3.13B
| $3.38M | 0.01% |
42,500
+18,600
| +78% | +$1.55M |
|
|
HA
1522
DELISTED
Hawaiian Holdings, Inc.
HA
| $3.37M | 0.01% |
250,302
+195,385
| +356% | +$2.82M |
|
1523
STAG Industrial
STAG
$7.38B
| $3.36M | 0.01% |
162,196
+149,564
| +1,184% | +$3.45M |
|
|
IPHS
1524
DELISTED
Innophos Holdings, Inc.
IPHS
| $3.35M | 0.01% |
60,849
+21,394
| +54% | +$1.24M |
|
|
XCO
1525
DELISTED
Exco Resources
XCO
| $3.35M | 0.01% |
66,838
+39,125
| +141% | +$2.74M |
|
Similar funds
Millennium Management's Q3 2014 Portfolio in Review
As of Q3 2014, Millennium Management held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Millennium Management deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Millennium Management's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Millennium Management added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Millennium Management's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Millennium Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Millennium Management opened 1,066 new positions and closed 749 in Q3 2014.
- Millennium Management's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.